Heart disease in psoriasis - 19/08/11
Rochester, Minnesota, and Thousand Oaks, California
Abstract |
Psoriasis has been traditionally viewed as an inflammatory skin disorder of unknown origin. Recent advances in the immunopathogenesis and genetics of psoriasis have broadened our understanding of psoriasis. Psoriasis is now considered a systemic inflammatory condition analogous to other inflammatory immune disorders. Patients with other immune disorders, such as systemic lupus erythematosus or rheumatoid arthritis, are known to be at increased risk of heart disease. Similarly, patients with psoriasis may carry an excess risk of heart disease, which would represent an important previously unrecognized cause of morbidity and mortality. This review summarizes the current evidence for an increased cardiovascular risk in patients with psoriasis and outlines deficits in our knowledge in this area.
Le texte complet de cet article est disponible en PDF.Plan
Funding sources: None. Disclosure: Dr Dann is an employee of Amgen Inc. Aside from Dr Dann’s intellectual contributions, no funding or other support from industry was received for this work. Drs Maradit Kremers, McEvoy, and Gabriel have received funding from Amgen Inc for separate research on a related topic. |
Vol 57 - N° 2
P. 347-354 - août 2007 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?